InvestorsHub Logo

Jamis1

10/31/14 10:04 AM

#31710 RE: TedJ #31709

Nice find, Ted. Thanks for connecting the dots to MKM.

TedJ

10/31/14 1:07 PM

#31718 RE: TedJ #31709

More random info on MetaStat 10-K:

We are a development stage life sciences company focused on developing and commercializing novel diagnostic technologies and therapeutics for the early and reliable prediction and treatment of systemic metastasis - cancer that spreads from a primary tumor through the bloodstream to other areas of the body. Systemic metastasis is responsible for greater than 90% of all solid tumor cancer related deaths and as such, we believe more accurate risk stratification and effective treatment of metastatic disease and/or the prevention of systemic metastasis is needed to improve patient outcomes.



Recent article on MetaStat:

http://medcitynews.com/2014/09/diagnostics-company-uses-epigenetics-principles-develop-metastatic-breast-cancer-test/

I believe Hawk and the boys have posted some recent articles about cancer and metastasis tumors detection with QDs.

Nothing solid here but a remote possibility. The other really weird item from the 10-K is:

MetaStat, Inc. (“we,” “us,” “our,” the “Company,” or “MetaStat”) formerly known as Photovoltaic Solar Cells Inc. (“PVSO”) was incorporated on March 28, 2007 under the laws of the State of Nevada. From inception until November of 2008, PVSO’s business plan was to produce and market inexpensive solar cells and in November 2008, our board of directors determined that the implementation of our business plan was no longer financially feasible. At such time, we discontinued the implementation of our prior business plan and pursued an acquisition strategy, whereby we sought to acquire a business. Based on these business activities, until February 27, 2012, we were considered a "blank check" company, with no or nominal assets (other than cash) and no or nominal operations.